Home Your basket
• Diagnosis and treatment o...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• Multi-factorial analysis ...
   Price 10.50 €
• From barotrauma otitis to...
   Price 8.50 €
• Interstitial brachytherap...
   Price 8.50 €
• Minimising radiation dose...
   Price 5.50 €
• Monolingualism, an overlo...
   Price 5.50 €
• Post-traumatic carotid ca...
   Price 8.50 €
• Termino-terminal hypoglos...
   Price 10.50 €
• Kikuchi Fujimoto, one cas...
   Price 10.50 €
• Surgical exploration of t...
   Price 10.50 €
• Characteristics of the ma...
   Price 12.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Tuberculous acute mastoid...
   Price 5.50 €
• Management of labial inco...
   Price 10.50 €
• Facial threads for face l...
   Price 10.50 €
• A detailed examination of...
   Price 10.50 €
• Voice rehabilitation afte...
   Price 10.50 €
• Surgical management of ma...
   Price 10.50 €
• Investigations on the ton...
   Price 10.50 €
• Treatment of severe epist...
   Price 5.50 €
• Transit time of swallowin...
   Price 10.50 €
• Blepharoplasty and upper ...
   Price 10.50 €
• Facial nerve monitoring i...
   Price 10.50 €
• Management of cerebellopo...
   Price 10.50 €
• Anatomic evaluation of th...
   Price 10.50 €
• Ectopic thyroid basi-ling...
   Price 10.50 €
• Study of tongue pressure ...
   Price 12.00 €
• Congenital cholesteatoma ...
   Price 5.50 €
• Aspects of voice quality ...
   Price 5.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Assumptions in surgical t...
   Price 8.50 €

Total Order 301.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2000 o

LARYNGOLOGY

Evaluation of the primary tumour and the metastatic lymph node with or without extracapsular spread by means of argyrophillic nucleolar regions (AgNOR)


Authors : C. Bilgen, S. Sarioglu, K. Ceryan (Izmir)

Ref. : Rev Laryngol Otol Rhinol. 2000;121,3:155-159.

Article published in english
Downloadable PDF document english



Summary : Though TNM staging is the most popular clinical system for defining the prognosis of Head and Neck Squamous Cell Carcinoma (HNSCC), different clinical trials of the tumours with the same TNM stage have caused doubts about this system. Extra Capsular Spread (ECS) in a metastatic lymph node is one of the recently defined prognostic factors in HNSCC. The hypothesis of this study was to assess the relationship between the primary tumour of laryngeal and oral cavity squamous cell carcinoma and the metastatic lymph nodes with and without ECS. The argyrophillic Nucleolar Organiser Regions (AgNOR) count was used as an index of the grade of malignancy of the neoplastic tissue. As a result, significantly higher AgNOR counts were obtained in the metastatic lymph nodes with ECS than in the primary tumours, while the lowest AgNOR counts were found in the metastatic lymph nodes without ECS. However, when primary tumours of the metastatic lymph nodes with ECS and the primary tumours of the metastatic lymph nodes without ECS were compared, no significant difference was found.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE